Trying DAILIES TOTAL1 Multifocal Lenses in satisfied INFUSE wearers
Official title: Clinical Outcomes Following Refit From INFUSE One-Day Multifocal to DAILIES TOTAL1 Multifocal in Satisfied Presbyopic Wearers: A Prospective, Open-Label, Single-Arm Study
Run by Gordon Schanzlin New Vision · NCT07638943 · Data updated 2026-11-12
This study tests whether switching satisfied INFUSE One-Day Multifocal wearers to DAILIES TOTAL1 Multifocal lenses maintains comfort and clear vision.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Gordon Schanzlin New Vision Academic / other |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT07638943 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40 and older who are currently satisfied INFUSE One-Day Multifocal wearers, wear lenses at least 8 hours daily, and have mild dry-eye symptoms but good overall vision.
✕Probably not a fit
Patients with active ocular infection, inflammation, severe dry eye, or uncontrolled systemic conditions may not benefit from this refitting approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines comfort and vision when refitting experienced INFUSE One-Day Multifocal wearers with DAILIES TOTAL1 Multifocal lenses. Eligible participants are 40 years and older who currently wear INFUSE multifocal lenses and meet daily-wear and dry-eye criteria. The study focuses on lens materials that support a healthy tear film and stable optical performance over extended wear. Participants will wear the DAILIES TOTAL1 Multifocal lenses for at least 8 hours per day, five days a week, and complete study questionnaires to assess comfort and vision outcomes. The approach aims to determine if a high-oxygen water-gradient or osmoprotective lens design can sustain physiological comfort without compromising visual clarity.
Why it matters
Potential benefit: If successful, participants may experience improved all-day comfort and stable near-to-distance vision with a lens that better supports the tear film.
How similar studies have gone: Prior multifocal lens work has shown variable comfort with refitting; this study explores a newer lens material in a specific prior-wear population, generating novel data for this niche group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age ≥40 years at enrollment Current satisfied wearer of Bausch + Lomb INFUSE One-Day Multifocal (kalifilcon A) in both eyes; Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) score \<12 at baseline Minimum contact lens wear of ≥8 hours/day, ≥5 days/week, for ≥30 days prior to Visit 1 Best-corrected distance visual acuity ≥20/25 (0.18 LogMAR) or better in each eye Manifest refraction within study lens parameters (Sphere: +6.00 D to -10.00 D; Add: Low, Medium, High) Willing to wear DAILIES TOTAL1 Multifocal lenses for ≥8 hours/day, ≥5 days/week and complete all study questionnaires Able to provide written informed consent and comply with investigator instructions Exclusion Criteria: Active ocular infection, inflammation, or clinically significant ocular surface disease (e.g., severe dry eye, pterygium, keratoconus) Uncontrolled systemic disease or use of systemic medications known to significantly affect the tear film, unless on a stable dose for ≥90 days History of refractive surgery (LASIK, PRK, RK) or intraocular surgery (cataract or IOL implantation) Clinically significant ectropion, entropion, or trichiasis Baseline corneal fluorescein staining score \>2 in any single zone (NEI/Industry scale) Current monovision or modified monovision contact lens wear Pregnant or lactating participants Participation in another clinical trial within 30 days prior to enrollment
Where it's running
-
Gordon Schanzlin New Vision Institute
La Jolla, California, United States Recruiting
Study contacts
- Study coordinator: David Geffen, OD, FAAO
- Email: dgeffen@gwsvision.com
- Phone: 8584556800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if the Morrow eProgressive lenses work better than standard PALs for presbyopia
This study tests whether the electronically adjustable Morrow eProgressive lenses help people with presbyopia see and move more naturally compared with traditional progressive lenses.
-
Volumetric visual fields with occupational vs general-purpose progressive lenses in presbyopia
This study tests whether two occupational progressive lenses and a general-purpose PAL give different depth of clear vision at multiple distances for people with presbyopia.
-
VisAbility Micro Insert System for Presbyopia
A new device called the VisAbility Micro Insert System is being tested to see if it can improve near vision at reading distance for adults with presbyopia.
-
Volumetric visual fields with progressive lenses for presbyopia at intermediate and near distances
Researchers will test two occupational progressive lenses to see which provides a larger clear field at intermediate and near distances for people with presbyopia.
-
Total30 Multifocal Toric Contact Lenses in Presbyopic Toric Wearers
This study tests whether Total30 MFT toric contact lenses are comfortable and acceptable for people who already wear reusable toric lenses and are now presbyopic.
-
A Smart Aperture Lens to Help Keratoconus and Presbyopia
This study tests the NOA lens, a custom scleral contact lens with a central aperture, to see if it improves vision for people with keratoconus and presbyopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.